Product Pipeline
ShilpaBio is leveraging its core capabilities in molecular biology, cancer biology and translational sciences to build a pipeline of affordable biologic therapies.
Our Pipeline Products
Program
Indication
- Dev. Disc.
- Pre-Clinical Pre-clinical
- Ph1 Phase 1
- Ph2 Phase 2
- Ph3 Phase 3
- La Launch
Etanercept Biosimilar SBDM-01
Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis
Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis
- Phase 1
Adalimumab Biosimilar SBDM-02
Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn’s Disease
Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn’s Disease
- Launch
Aflibercept Biosimilar SBDM-03
Neovascular (Wet) Age-Related Macular Degeneration
Neovascular (Wet) Age-Related Macular Degeneration
- Phase 3
Abatacept Biosimilar SBDM-04
Adult Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis
Adult Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis
- Pre-C
SBDM-05
Myocardial Infarction
Myocardial Infarction
- Dev.
SBDM-06
Anemia associated with Chemotherapy
Anemia associated with Chemotherapy
- Dev.
SBDM-07
Ovarian hyperstimulation
Ovarian hyperstimulation
- Dev.
SBDM-08
Colon Cancer, Lung Cancer
Colon Cancer, Lung Cancer
- Dev.
SBDM-09
Lung cancer, Head & Neck cancer
Lung cancer, Head & Neck cancer
- Dev.
SBDM-010
Multiple Myeloma
Multiple Myeloma
- Dev.
SBDM-011
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
- Dev.